Other
Other Noncash Income (Expense)
Roivant Sciences Other Noncash Income (Expense) increased by 46.0% to -$5.98M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 133.3%, from $17.94M to -$5.98M. Over 2 years (FY 2022 to FY 2024), Other Noncash Income (Expense) shows a downward trend with a -57.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2020
Last reportedQ2 2025Nov 10, 2025
Metric ID:
other_other_noncash_income_expenseHistorical Data
17 periods
| Q1 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$838.00K | $1.92M | -$1.78M | -$6.58M | -$2.14M | $16.78M | $13.14M | $5.64M | -$10.94M | $37.14M | -$42.10M | -$5.58M | $17.94M | -$11.90M | -$4.23M | -$11.08M | -$5.98M |
| QoQ Change | — | +329.0% | -192.7% | -270.1% | +67.6% | +886.0% | -21.7% | -57.1% | -293.9% | +439.7% | -213.3% | +86.8% | +421.7% | -166.3% | +64.5% | -162.2% | +46.0% |
| YoY Change | — | — | — | -685.3% | — | +774.5% | +839.0% | +185.7% | -412.2% | +121.3% | -420.4% | -198.9% | +264.0% | -132.0% | +90.0% | -98.7% | -133.3% |
Range-$42.10M – $37.14M
CAGR+63.4%
Avg YoY Growth+14.9%
Median YoY Growth-98.7%
Other Noncash Income (Expense) at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's other noncash income (expense)?
- Roivant Sciences (ROIV) reported other noncash income (expense) of -$5.98M in Q3 2025.
- How has Roivant Sciences's other noncash income (expense) changed year-over-year?
- Roivant Sciences's other noncash income (expense) decreased by 133.3% year-over-year, from $17.94M to -$5.98M.
- What is the long-term trend for Roivant Sciences's other noncash income (expense)?
- Over 2 years (2022 to 2024), Roivant Sciences's other noncash income (expense) has grown at a -57.9% compound annual growth rate (CAGR), from $21.21M to -$3.76M.